isuceda.cn-精品无码人妻一区二区免费蜜桃,国产成人AV乱码在线观看,高潮抽搐潮喷毛片在线播放,九七电影院97网手机版不用下载

歡迎您來到泰方機械有限公司網站!
Suzhou Taifang wire cable machinery Co.,Ltd.
7X24小時服務熱線:

+86-138-1293-0229

熱門關鍵詞:

聯系我們

Suzhou Taifang wire cable machinery Co.,Ltd.

聯系人:Mr.Zhong
郵 箱:121740864@qq.com
電 話:+86-138-1293-0229
地 址:579 Qianjin East Road, Kunshan Development Zone, Jiangsu Province

您的位置:首頁 >> News >> Industry News

Kobayashi Pharmaceutical In 'Red Yeast Rice Supplementary Crisis' |5 Deaths and 1.8 Bln Yen Potential Recall Cost Might End Its 26 Years of Net Profit Growth

發布時間:2024-04-06人氣:697

The ongoing health crisis related to Japanese pharmaceutical company Kobayashi Pharmaceutical continues to escalate. On March 30, the health ministry and local authorities on Saturday inspected one of its factories.

Kobayashi Pharmaceutical has so far reported a total of five deaths and the hospitalizations of more than 114 people as possibly linked to the red yeast rice dietary supplements. 

The drugmaker as well as Japan's health ministry said the company's examination unexpectedly found puberulic acid, a natural compound made from blue mold, in the products. The ministry said the substance is a potent antibacterial and antimalarial agent that can be toxic. However, it remains unclear how this highly toxic substance found its way into the products and what impact it has on the kidneys.

Kobayashi Pharmaceutical previously announced a voucher of 2,500 yen (around 16 U.S. dollars) will be provided per item as compensation. There will be no differentiation in compensation for consumers both from home and abroad once the causal relationship is established.

The factory in western Japan, which was making the ingredients of the supplements, shut down in December, and the equipment has since been transferred to Wakayama Prefecture.

The affected health products were primarily produced between April and October 2023, with market availability from July to December 2023. Currently, 173 companies that used Kobayashi Pharmaceutical’s red yeast rice raw material for production are conducting voluntary self-inspections. Out of the 18.5 tons of beni-koji raw material manufactured by Kobayashi Pharmaceutical in 2023, approximately 16.1 tons were sold to external parties.

Additionally, due to the export of red yeast rice raw material, Japanese authorities notified the World Health Organization (WHO) on March 28. The impact of this crisis extends beyond Japan, potentially affecting the global perception of Japanese health products.

Kobayashi Pharmaceutical, a century-old company, heavily relies on health products in its domestic business, accounting for over 50% of its sales. In its 2023 financial report, the company expressed plans to strengthen this category’s overseas development, aiming to increase the share of health product sales in overseas markets from 20% in 2023 to 35% by the end of 2030.

Dr. Wang Yong, initiator and chairman of the China Brand Festival and director of the Brand Alliance, expressed in an interview with the National Business Daily that the impact of the recall on Kobayashi Pharmaceutical is evident. First, sales of affected health products are expected to plummet. Second, the company must allocate substantial funds for product recalls, compensating victims, and improving production processes. Additionally, legal litigation arising from the incident may further strain the company.

From a brand image perspective, this event poses a severe blow to Kobayashi Pharmaceutical. Once a trust crisis takes root, repairing it within a short timeframe becomes challenging. Notably, several Japanese health supplement brands, represented by Kobayashi, have intensified brand promotion and marketing in China in recent years. They have launched numerous popular products, some even earning the moniker “Japanese miracle drugs.” Consequently, this recall incident could erode consumer trust in all Japanese health supplements, potentially impacting long-term sales in the Chinese market.

As the controversy continues to unfold, industry insiders speculate that Kobayashi Pharmaceutical may exit the nutritional supplement and health product market. Institutions, including SMBC Nikko Securities, estimate the recall cost at 1.8 billion Japanese yen (approximately 11.9 million US dollars), with the possibility of further escalation. This projected cost could lead to a 6% decline in the company’s expected net income for the current fiscal year. As a result, Kobayashi Pharmaceutical’s stock price has cumulatively dropped by 15.87% this week.

However, analysts from Morgan Stanley, led by the Wako Sato team, suggest that while the recall is negative news, its impact on Kobayashi Pharmaceutical’s stock price may be transient. They believe that despite the recall’s significant scale, its effects on other Kobayashi products remain limited within a defined range.

Nevertheless, Nikkei News reports that Kobayashi Pharmaceutical has already ceased television advertising and other promotional activities as part of its core marketing strategy. When a company’s image falters, the efficacy of advertisements weakens, and consumers may choose to disengage. The current situation indicates an increasing risk of spillover effects on other goods. If these effects become pronounced, they could undermine the company’s operational foundation.


蘇州泰方機械有限公司
產品分類一覽表
高速押出機系列
電子線押出機電源線押出機光伏線押出機汽車雙色線押出機民用線設備
低煙無鹵押出機BV線押出機電力電纜押出機鐵氟龍押出機硅膠線押出機
氟塑料擠出機輻照橡膠線押出機橡膠硫化擠出機物理發泡押出機化學發泡押出機
高速串聯生產線扁銅帶押出機三層絕緣導線押出機纖維打包帶設備銅排擠出機
3D打印膠條設備 造粒機


高速絞線機系列
200P高速絞線機300P高速絞線機400P高速絞線機500P高速絞線機630P高速絞線機
800P高速絞線機1000P高速絞線機1250P高速絞線機高絞機絞絲機
絞銅機絞線機束絞機束絲機銅線機
單絞成纜機系列
懸臂式單絞成纜機630型懸臂式單絞機800型懸臂式單絞機1000型懸臂式單絞機1250型懸臂式單絞機
旋框式單絞成纜機630型旋框式單絞機800型旋框式單絞機1000型旋框式單絞機1250型旋框式單絞機
立式單絞機臥式單絞機


雙絞成纜機系列
630型雙絞成纜機800型雙絞成纜機1000型雙絞成纜機1250型雙絞成纜機雙絞成纜機
退扭對絞機系列
500型小懸臂高速對絞機高速絞對機立式對絞機立式退扭機
三倍退扭對絞機雙盤退扭機退扭對絞機臥式對絞機臥式退扭機
高速繞包機系列
包紙機薄膜繞包機高速包絲機高速絲包機換位導線紙包機
立式單層繞包機立式繞包機立式三層繞包機立式雙層包帶機立式雙層繞包機
立式雙頭雙層繞包機立式紙包機膜包機四對繞包機銅帶紙包機
臥式單層繞包機臥式多層繞包機臥式多層紙包機臥式繞包機臥式雙層包帶機
臥式雙層繞包機云母帶繞包機紙包機組合導線紙包機
Type-C立式纏繞雙包機極細線全自動高速繞包機臥式紙包機PTFE四氟薄膜繞包燒結機 
自動成圈機系列
小截面成圈打扎機中截面成圈打扎機大截面成圈打扎機立式網狀成圈機臥式網狀成圈機
梅花落桶機自動搖盤機自動搖盤包膜機1040型電線搖盤包膜機1860型電纜搖盤包膜機
放線機系列
立式張力放線架臥式張力放線架日式雙軸放線架日式磁粉張力放線架單軸主動張力放線架
高速主動放線架無軸式磁粉張力放線架無軸式主動張力放線架雙軸主動張力放線機雙軸主動張力放線架
多頭并絲銅線放線架多頭主動張力放線架甩桶放線架端軸式放線架龍門式放線架
收線機系列
單軸收線機雙軸收線機無軸式收線機無軸式雙軸收線機磁條收卷機
自動換盤收線機象鼻式牽引收線機梅花落桶收線機端軸式收排線架龍門式收排線機
拉絲機系列
細微拉絲機微拉機微拉連續退火機小拉機雙頭小拉機
小拉連續退火機中小拉機中小拉連續退火機雙頭小拉連續退火機中拉機
中拉連續退火機雙頭中小拉機中大拉連續退火機大拉連續退火機多頭拉連續退火機
8頭拉連續退火機16頭拉連續退火機并絲放線機并絲收線機小拉自動換盤機
緊密收線機梅花落線機退火鍍錫機

其它電工設備
叉式絞線機管式絞線機框式絞線機籠式絞線機搖藍式成纜機
銅帶鎧裝機



周邊輔助設備
履帶牽引機高速裁線機高速纏繞機卷磁機彩排并線機
復繞機-倒軸機立式注條機臥式注條機加熱型過粉機工頻火花機
高頻火花機激光測徑儀銅線預熱器銅粉過慮器上色過油機
雙輪張力機自動裁線機自動混料機機頭與模具


TAG:
在線客服
服務熱線

服務熱線

+86-138-1293-0229

微信咨詢
Suzhou Taifang wire cable machinery Co.,Ltd.
關注抖音
Suzhou Taifang wire cable machinery Co.,Ltd.
返回頂部